One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: binhai economic development zone, 262737, Weifang, Shandong, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Asia,Middle East,Africa
Monthly Production Capacity: 250
Packaging Information: 25kg bag, 500kg bag with pallet or as customer's requirement
Delivery Lead Time: 10-15 DAYS
Sample Provided: yes
Payment Terms: T/T
2-EAQ
2-Ethyl Anthraquinone
RAW MATERIAL FOR HYDROGEN PEROXIDE
CAS NO.: 84-51-5
Appearance: Light Yellow flake solid
Product Description:
Light yellow flake solid,melting point is lower than Anthraquinone, soluble in Benzene, melting point is 108℃
ITEMS
PREMIUM GRADE
FIRST GRADE
Appearance
Light Yellow flake solid
Content w/%≥
99.0
98.5
Melting point℃
108.0-112.0
108.0-112.0
Benzene insolubles%≤
0.05
0.10
Moisture %≤
0.2
0.2
CL ≤ppm
10
40
S ≤ ppm
5
5
Fe ≤ ppm
5
10
Application: It is mainly used as raw material in the production of Hydrogen Peroxide with Anthraquinone process. It is also used in the synthesis of pharmaceuticals, photochromics, dyes etc.
Packing: 25KG composite kraft paper bag with double lining, 500KG composite jumbo bag or according to customer requirement..
If you have any demand about my products.
please enquiry me sophia at kaihongchem dot com.
Our main products are 2-Ethyl-anthraquinone. Aluminum Chloride.Polyaluminium Chloride PAC.Bronopol.DBNPA.HBCD.Carbohydrazide. SodiumBromide. DBNE DBNPA20%.2-Cyanoacetamide.HBCD Masterbatch. BDDP. Sodium bromateFlake Graphiteetc.
Four years of qualification
Audited Supplier
Pharma Sources Insight January 2025
![Benzoesure, 4-[[6-[(1-oxo-2-propenyl)oxy]hexyl]oxy]-, 4-methoxyphenylester](https://eimg.pharmasources.com/image/20231229/fgV6bpg0zkDQp6BbsZpWbcMtu1bdKuVJlvhQBSL5.png!145)
